WASHINGTON--(BUSINESS WIRE)--Today, Representative Michael Fitzpatrick (R-PA) introduced H.R. 6161, the Fostering Innovation Act, to update SEC filing status classifications for public companies, which will help to ease regulatory burdens on emerging biotechnology companies and reduce the bureaucratic hurdles and red tape that lengthen the time to bring cures from discovery to patient.
